Study identifies new genetic signatures of breast cancer drug resistance
Tuesday, January 11, 2011 - 13:40
in Health & Medicine
A new study conducted by Josh LaBaer's research team in the Biodesign Institute at Arizona State University has pinpointed more than 30 breast cancer gene targets - including several novel genes - that are involved in drug resistance to a leading chemotherapy treatment...